Drug intelligence / Profile preview

ICE-T multimodal pain regimen

Development stage: Unknown
Lead developer: University of California, Irvine
Modality: Small Molecules
Administration: Oral, Intravenous, Intramuscular, Topical

Overview

ICE-T is a novel multimodal postoperative pain regimen designed to improve pain control and decrease opioid intake in patients undergoing vaginal pelvic floor reconstructive surgery. The regimen is composed of around-the-clock ice packs, ketorolac (Toradol), and acetaminophen (Tylenol).

Targets

COX

Beyond the preview

Go deeper on ICE-T multimodal pain regimen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ICE-T multimodal pain regimen.

Explore the full profile